Human Anti-DLL4 Recombinant Antibody (clone 61B) (CAT#: HPAB-1108-FY)

Figure 1 61B has no cross-reactivity to mouse Dll4.

The bound AP fusion proteins were detected using AP substrate and a plate reader. Experiment was performed in triplicate. Data are presented as mean ±SEM.

Zhou, B., Wang, H., Liu, R., Wang, M., Deng, H., Giglio, B. C., ... & Li, Z. (2015). PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using 64Cu-Labeled Monoclonal Antibody 61B. Molecular pharmaceutics, 12(10), 3527-3534.

Figure 2 Confocal fluorescence images of 61B-Cy5.5 and immunofluorescence staining of CD31 in HT29 tumor tissues.

Images were obtained under identical conditions and displayed at same magnification. Scale bar = 100 μm.

Zhou, B., Wang, H., Liu, R., Wang, M., Deng, H., Giglio, B. C., ... & Li, Z. (2015). PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using 64Cu-Labeled Monoclonal Antibody 61B. Molecular pharmaceutics, 12(10), 3527-3534.

Figure 3 IF result of 61B antibody.

61B-Alexa Fluor555 staining of U87MG cells in the absence (upper panel) and presence (lower panel) of excess amount of un-labeled 61B antibody.

Zhou, B., Wang, H., Liu, R., Wang, M., Deng, H., Giglio, B. C., ... & Li, Z. (2015). PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using 64Cu-Labeled Monoclonal Antibody 61B. Molecular pharmaceutics, 12(10), 3527-3534.